Stonepine Capital Management, LLC Durect Corp Transaction History

Stonepine Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$1.69 - $3.8 $169,000 - $380,000	-100,000 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$0.61 - $2.21 $61,000 - $221,000	100,000 New	100,000 $184,000
Q3 2017 Nov 13, 2017	SELL	$1.55 - $1.82 $4.92 Million - $5.78 Million	-3,175,994 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	3,175,994	3,175,994 $4.96 Million

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $175M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonepine Capital Management, LLC with notifications on news.